共 177 条
- [1] Gerich JE(2003)Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus Mayo Clin Proc 78 447-456
- [2] Haffner SM(1999)Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study Diabetes Care 22 562-568
- [3] D’Agostino R(2001)Mortality and causes of death in the WHO multinational study of vascular disease in diabetes Diabetologia 44 S14-S21
- [4] Mykkanen L(2001)Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone Diabetes Care 24 710-719
- [5] Morrish NJ(2004)Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association Diabetes Care 27 256-263
- [6] Wang S-L(2003)Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure J Am Coll Cardiol 41 1394-1398
- [7] Stevens LK(1999)Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group JAMA 281 2005-2012
- [8] Fuller JH(2004)Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial Am J Med 116 223-229
- [9] Keen H(2004)Improved glycemic control without weight gain using triple therapy in type 2 diabetes Diabetes Care 27 1577-1583
- [10] Miyazaki Y(1972)Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 499-502